Small beer, big ambition
Article Abstract:
Jennings Brothers operates pubs and is a brewer. The company manages 180 pubs following the acquisition of Cafe Inns in 1999. Mike Clayton, who was previously at Greenalls, is to become Jennings' managing director, and has experience of running 1,350 pubs as Greenalls' operating manager. The company also aims to sell beer using the internet, and already sells to supermarkets. The company's profit is forecast at 4 million pounds sterling for 1999 to 2000.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Luminar
Article Abstract:
Luminar should benefit from cost savings after buying Northern Leisure, and its nightclubs should benefit from changes in demography. The company could face competition with licensing law changes.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Shepherd Neame: old world Shepherd
Article Abstract:
Shepherd Neame sees vertical integration as advantageous in the brewing industry, unlike many other pub operators focusing in designer pubs and bulk buying. The company has invested in its brands which have seen a rise in sales. Shepherd Neame has also invested in land for a brewery expansion, and has invested in bottling and in its pubs, buying freeholds and selling pubs that were not performing well. The company faces competition in Kent, England, from beer imported from mainland Europe without duty having been paid.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The Rothschild dilemma. Same old bull. Living in a bubble
- Abstracts: Diluted IAS 39 is worst of all results. Power point. Keeping Canada at the standards table
- Abstracts: Scottish and Southern Energy. Scottish Power
- Abstracts: Powderject Pharmaceuticals. Powderject. PowderJect Pharmaceuticals